
Sign up to save your podcasts
Or


These comprehensive sources explore the molecular landscape, historical development, and clinical management of inherited retinal diseases, focusing specifically on Orphanet 1872 Cone-Rod Dystrophy (CRD). They detail the pathophysiology of photoreceptor degeneration, where primary cone loss leads to secondary rod failure, and highlight the extreme genetic heterogeneity involving over 30 distinct types. The literature identifies critical mutations in genes such as ABCA4, GUCY2D, and RPGR while documenting the evolving diagnostic roles of electroretinography and advanced retinal imaging. Furthermore, the texts examine biographical case studies like that of artist Edgar Degas to illustrate the progressive nature of central vision loss. A significant portion of the material evaluates modern reproductive strategies, specifically the use of preimplantation genetic testing (PGT-M) to prevent the transmission of these conditions. Finally, the sources review the future of vision restoration, covering breakthrough innovations in gene therapy, optogenetics, and subretinal photovoltaic implants.
By Robin Hendel, MDThese comprehensive sources explore the molecular landscape, historical development, and clinical management of inherited retinal diseases, focusing specifically on Orphanet 1872 Cone-Rod Dystrophy (CRD). They detail the pathophysiology of photoreceptor degeneration, where primary cone loss leads to secondary rod failure, and highlight the extreme genetic heterogeneity involving over 30 distinct types. The literature identifies critical mutations in genes such as ABCA4, GUCY2D, and RPGR while documenting the evolving diagnostic roles of electroretinography and advanced retinal imaging. Furthermore, the texts examine biographical case studies like that of artist Edgar Degas to illustrate the progressive nature of central vision loss. A significant portion of the material evaluates modern reproductive strategies, specifically the use of preimplantation genetic testing (PGT-M) to prevent the transmission of these conditions. Finally, the sources review the future of vision restoration, covering breakthrough innovations in gene therapy, optogenetics, and subretinal photovoltaic implants.